ValuEngine upgraded shares of Encompass Health (NYSE:EHC) from a hold rating to a buy rating in a report published on Monday, February 4th.
Several other equities research analysts also recently weighed in on the company. Jefferies Financial Group began coverage on Encompass Health in a report on Thursday, December 20th. They issued a buy rating for the company. Barclays started coverage on Encompass Health in a report on Friday, December 14th. They set an equal weight rating and a $75.00 target price for the company. Finally, UBS Group started coverage on Encompass Health in a report on Thursday, November 15th. They set a buy rating and a $86.00 target price for the company. Two investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Encompass Health currently has an average rating of Buy and a consensus target price of $74.88.
NYSE EHC traded up $0.63 during trading on Monday, hitting $63.77. The company’s stock had a trading volume of 553,756 shares, compared to its average volume of 711,184. The company has a debt-to-equity ratio of 1.54, a quick ratio of 1.05 and a current ratio of 0.98. The company has a market cap of $6.52 billion, a PE ratio of 17.57, a P/E/G ratio of 1.70 and a beta of 0.76. Encompass Health has a fifty-two week low of $53.19 and a fifty-two week high of $82.46.
Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, February 7th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.79 by $0.01. The business had revenue of $1.10 billion during the quarter, compared to the consensus estimate of $1.09 billion. Encompass Health had a return on equity of 23.54% and a net margin of 6.83%. On average, sell-side analysts predict that Encompass Health will post 3.77 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, April 15th. Investors of record on Monday, April 1st will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 1.69%. The ex-dividend date is Friday, March 29th. Encompass Health’s dividend payout ratio is currently 29.75%.
About Encompass Health
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Recommended Story: Lock-Up Period Expiration
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.